Economic Implications of Intellectual Property Rights for the Biotechnology Sector: A Comparative Analysis of the European-Japanese Situations.

Gilroy, Bernard Michael and Brandes, Wolfgang and Volpert, Tobias (2003): Economic Implications of Intellectual Property Rights for the Biotechnology Sector: A Comparative Analysis of the European-Japanese Situations.

Abstract

Under the assumption of similar general legal environments, the following analysis suggests that a strategy of confidential secrecy in R&D is less significant for Japanese enterprises. Founded upon this difference the amount of patent induced information disclosure effects for Japan is not as essential as it is for Europe. Consequently, the blockade effect in Japan is comparatively dominant, i.e. in Japan the negative aspects of patent protection effect the system more immediately. Thus, one might argue that less patent protection is more fruitful for Japan. Given this analysis, the current endeavours of the USA, the European Union and Japan to harmonize patent legislation for the biotechnology sector appears to be flawed.

• Item Type: MPRA Paper
• Language: English
• Keywords: Patent; biotechnology; international harmonization
• Subjects: L - Industrial Organization > L0 - General; F - International Economics > F0 - General

References

Artuso, A. (1997): Drugs of Natural Origin: Economic and Policy Aspects of Discovery, Development, and Marketing. Pharmaceutical Product Press, New York, London.

Bessen, J., Maskin, E. (2001): Sequential innovation, patents, and imitation. Working Paper No. 00-01. Massachusetts Institute of Technology.

De Laat, E.A. (1997): Essays on Patent Policy. The Multi-dimensionality of Patents and Asymetric Information. Dissertation, Erasmus University Rotterdam.

Ernst and Young (2002): Beyond Borders: The global biotechnology report 2002. Ernst and Young, Cleveland, Ohio.

Gilbert, R., Shapiro C. (1990): Optimal patent length and breadth. RAND Journal of Economics 21: 106-112.

Gilroy, B.M., Volpert, T. (2002): Economic insights and deficits in european biotechnology patent policy. Intereconomics 37: 150-155.

Hullmann, A. (2001): Internationaler Wissenstransfer und technischer Wandel. Physica-Verlag, Heidelberg.

Klemperer, B. (1990): How broad should the scope of patent protection be? RAND Journal of Economics 21: 113-130

OECD (2002): Genetic Inventions, Intellectual Property Rights and Licensing Practices. OECD, Paris, France.

Simon, J., Braun, S. (2002): Patentrecht und Biotechnologie: Patente auf Leben? Arbeitsbericht Nr. 261, Universität Lünerburg.

Spaethe, T.U. (2001): Die Pharmaindustrie und die Biotechnologie. Dissertation, page 256.

Zucker, L.G., Darby, M.R., Brewer, M.B. (1998): Intellectual human capital and the birth of U.S. biotechnology enterprises. American Economic Review 88: 290-306.